Cargando…

Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine

Lung cancer is the leading cause of cancer death among both men and women in the United States. Because lung cancer is genetically heterogeneous, tailored therapy alone or in combination with chemotherapy would increase patient overall survival as compared with the one-size-fits-all chemotherapy. TP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaohong Mary, Gavande, Navnath, Parajuli, Prahlad, Bepler, Gerold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570638/ https://www.ncbi.nlm.nih.gov/pubmed/34746935 http://dx.doi.org/10.46439/cancerbiology.2.015

Ejemplares similares

The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
por: Hu, Chen, et al.
Publicado: (2020)

HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
por: Moses, Niko, et al.
Publicado: (2020)

Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells
por: Wang, Lei, et al.
Publicado: (2012)

Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders
por: Karim, Nasiara, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage Response
por: Ainembabazi, Diana, et al.
Publicado: (2022)

Implications of the HDAC6-ERK1 feed-forward loop in immunotherapy
por: Wu, Jheng-Yu, et al.
Publicado: (2018)

Nanomedicine approaches to reduce cytokine storms in severe infections
por: Ahmar Rauf, Mohd, et al.
Publicado: (2022)

USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia
por: Liao, Yuning, et al.
Publicado: (2019)

The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19
por: Prasad, Ananda S., et al.
Publicado: (2022)

Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer
por: Yu, Shiyi, et al.
Publicado: (2017)

Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells
por: Borbely, Gabor, et al.
Publicado: (2015)

HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis
por: Gu, Yuan Yuan, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis: the complex path to precision medicine
por: Talbot, Kevin, et al.
Publicado: (2018)

Thinking Machines and Risk Assessment: On the Path to Precision Medicine
por: Garratt, Kirk N., et al.
Publicado: (2019)

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
por: Kelm, Jeremy M., et al.
Publicado: (2023)

A Method for Biomarker Directed Survival Prediction in Advanced Non-Small-Cell Lung Cancer Patients Treated with Carboplatin-Based Therapy
por: Chen, Wei, et al.
Publicado: (2013)

Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability
por: Ma, Zhi-Qiang, et al.
Publicado: (2022)

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
por: Guo, Kai, et al.
Publicado: (2022)

HDAC6 and Ovarian Cancer
por: Haakenson, Joshua, et al.
Publicado: (2013)

A Path to Implement Precision Child Health Cardiovascular Medicine
por: Touma, Marlin, et al.
Publicado: (2017)

HDAC10 promotes angiogenesis in endothelial cells through the PTPN22/ERK axis
por: Duan, Baoyu, et al.
Publicado: (2017)

USP38 regulates the stemness and chemoresistance of human colorectal cancer via regulation of HDAC3
por: Zhan, Wei, et al.
Publicado: (2020)

HDAC6 regulates IL-17 expression in T lymphocytes: implications for HDAC6-targeted therapies
por: Yan, Bing, et al.
Publicado: (2017)

Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine
por: Hugen, Cory M., et al.
Publicado: (2017)

Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment
por: Harris, Eleanor E. R.
Publicado: (2018)

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
por: Hampel, Harald, et al.
Publicado: (2020)

The paths of Graves’ disease in the 21st century: precision medicine is closer
Publicado: (2020)

NIH Precision Medicine Initiative: Implications for Diabetes Research
por: Fradkin, Judith E., et al.
Publicado: (2016)

Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease
por: Kulka, Linda Anna Michelle, et al.
Publicado: (2020)

USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
por: Li, Z, et al.
Publicado: (2016)

USP19 deubiquitinates HDAC1/2 to regulate DNA damage repair and control chromosomal stability
por: Wu, Min, et al.
Publicado: (2016)

A path to precision in the ICU
por: Maslove, David M., et al.
Publicado: (2017)

Implementation of Precision Cancer Medicine: Progress and the Path to Realizing the Promise of Tumor Sequencing
por: Bradbury, Angela R.
Publicado: (2019)

A Path to Precision Medicine: Incorporating Blood-Based Biomarkers in Stroke Rehabilitation
por: Oh, Byung-Mo
Publicado: (2021)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

Precision medicine and implications in medical education
por: Lamichhane, Pratik, et al.
Publicado: (2023)

Ubiquitination and Degradation of Ribonucleotide Reductase M1 by the Polycomb Group Proteins RNF2 and Bmi1 and Cellular Response to Gemcitabine
por: Zhang, Yingtao, et al.
Publicado: (2014)

Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks
por: Mendoza-Munoz, Pamela L, et al.
Publicado: (2023)

Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer
por: Zeng, Zhi, et al.
Publicado: (2019)

Inhibition of the deubiquitinase USP10 induces degradation of SYK
por: Yang, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_226k81rm9uf70ugaa1nc9nbobn